Background -Schipperkes develop bilaterally symmetrical alopecia preceded by lightening of the hair coat not associated with systemic clinical signs. The alopecia is presumptively diagnosed as Alopecia X but has never been investigated.
Introduction
Alopecic disorders in dogs are often the source of frustration for dog owners as well as veterinarians. Although some alopecic disorders are inflammatory in nature, the most problematic cases are often noninflammatory with a symmetrical appearance. Diseases routinely associated with noninflammatory symmetrical alopecia include endocrinopathies such as hypothyroidism, hyperadrenocorticism, sex hormone imbalances and a frequently renamed syndrome currently referred to as Alopecia X.
1-3 Alopecia X typically affects double-haired "plush-coated" breeds such as the chow chow, Pomeranian and Alaskan malamute; the miniature poodle also has been reported as a commonly affected breed. [3] [4] [5] The Pomeranian is considered to be the prototype for this syndrome, given the bulk of published studies on this breed. The alopecia affects young adult dogs and is characterized by loss of the outer guard hairs with progression to complete alopecia sparing the head and distal extremities, often with concurrent hyperpigmentation of the skin. The pathomechanism of Alopecia X is currently unknown; studies have failed to show an association between hormonal abnormalities and the alopecia. 6, 7 The diagnosis is based on the clinical presentation and exclusion of the endocrinopathies mentioned, as well as histopathological evaluation demonstrating hair cycle arrest.
An alopecic disorder mirroring the features and progression of Alopecia X has been recognized by schipperke breeders. Schipperkes are a double-coated breed with outer guard hairs and inner secondary hairs comprising the plush coat. Affected schipperkes typically experience lightening or red discolouring of the truncal hair before the onset of alopecia. Like Alopecia X, the head and distal extremities remain unaffected. Although many reports have detailed this type of disorder in other plushcoated breeds, 1, 4, 8, 9 to the best of the authors' knowledge, description of a noninflammatory alopecic disorder in the schipperke has not been reported. The aim of this prospective study was to describe the clinical, histopathological and laboratory features of a symmetrical, noninflammatory hair coat disorder in schipperkes.
Methods and materials
Prior informed owner consent was obtained, and the Institutional Animal Care and Use Committee approved the study. Schipperke dogs with clinical findings typical of a noninflammatory hair coat disorder with no other systemic signs were recruited nationwide. One dog was evaluated by the primary investigator. The remaining cases were enrolled using information obtained from primary care veterinarians. Three unaffected schipperke dogs deemed healthy based upon routine physical examination findings and absence of clinical history of illness were recruited. The healthy dogs had not received any treatments other than routine parasite prophylaxis within the six months before enrolment. Eight schipperke dogs with symmetrical noninflammatory alopecia were identified and enrolled in the study.
All dogs underwent additional diagnostic testing. Except for the one locally available dog (Dog 5), all blood and urine samples for tests performed were obtained by primary care veterinarians and shipped to the primary investigator overnight on cooling packs. Complete blood count (CBC), serum chemistry panel and urinalysis (UA) were performed by the clinical pathology laboratory at the primary investigator's institution. Thyroid evaluation, including total thyroxine (T 4 ), free thyroxine by equilibrium dialysis (fT 4 ed) and thyroid stimulating hormone (TSH) concentrations for all dogs were performed by ANTECH laboratories (ANTECH Diagnostics; Southaven, MS, USA). Cortisol and adrenal sex and steroid hormone intermediate concentrations were evaluated both pre-and postadrenocorticotropic (ACTH) stimulation by the Clinical Endocrinology Laboratory at the College of Veterinary Medicine, University of Tennessee; Knoxville, TN, USA. Cosyntropin (Cortrosyn â , Amphastar Pharmaceuticals, Inc.; Rancho Cucamonga, CA, USA) was provided by the primary investigator and shipped to each primary care veterinarian as a single vial of sterile lyophilized powder with instructions for reconstitution. Serum was collected before and 1 h post-intravenous administration of 5 lg/kg cosyntropin. Hyperadrenocorticism was excluded by cortisol concentrations post-ACTH stimulation of <18 lg/dL 10 and absence of clinicopathological abnormalities from the screening laboratory work. A first morning urine sample collected by the owner in the home environment was submitted for determination of a urine cortisol: creatinine ratio (UCCR) by IDEXX laboratories (IDEXX Laboratories; Westbrook, ME, USA). A UCCR <13.5 was interpreted as normal. Skin biopsies from healthy dogs, and from haired and alopecic areas of affected dogs were obtained and evaluated. All prior topical treatments and oral (p.o.) drug administrations (drug name, dosage and duration) were obtained from the medical records to determine whether any changes in the hair coat may have been influenced by prior therapy.
Results

Dog signalment and history
Of the three healthy dogs, two were male (one castrated) and one was an intact female. The affected group comprised three male dogs (two castrated) and five female dogs (three spayed). Two healthy dogs (dogs 2 and 3) and an affected dog (Dog 4) were related; Dog 3 was the dam and Dog 2 was a littermate of Dog 4. At the time of enrolment, healthy dogs were aged between three and seven years (median 5.0 years); affected dogs were aged between four and 10 years (median 6.5 years). The owners of two of the affected dogs (dogs 6 and 11) reported knowledge of related dogs with reddish coat colour changes. Weights of the dogs ranged from 6.5 to 8.9 kg (median 7.2 kg).
Development of progressive alopecia in the eight affected dogs (dogs 4-11) began between six months and six years (median 3.0 years). All affected dogs had coat colour changes from black to a reddish brown, before the development of any hair loss or texture changes (Figure 1a,b) . The owner of Dog 9 noted a reddish coat colour change as early as six months of age, with hair loss not beginning until four years of age. Four of eight affected dogs did not regrow any portion of the lost coat following initial loss. Of the four dogs that did have hair growth, dogs 5 and 8 grew black, coarse hair at sites of previous skin biopsy, but not in any other areas (Figure 1c,d ). Dog 9 developed regional alopecia over the shoulders and caudal thighs with periods of hair regrowth in between rather than a generalized truncal alopecia; the rest of the truncal hair coat persisted with a reddish coat colour and harsh texture change. Dog 10 had partial regrowth with the hair a softer texture than before. All dogs were nonpruritic and abnormalities affected the truncal hair coat primarily, sparing the head and extremities.
Previous therapies including a variety of diet changes (raw, grain free, hypoallergenic, home-cooked), dietary supplements and topical treatments such as medicated shampoos and/or sprays, failed to improve the coat colour, texture or stimulate hair growth in any of the affected dogs. Dogs 5, 6, 10 and 11 were treated with melatonin supplementation p.o.; dogs 5, 10 and 11 were treated with 3 mg twice daily, resulting in partial regrowth for Dog 10 and no improvement for dogs 5 or 11 after one year of treatment. The dose for dogs 5 and 11 was then increased, and dogs 5, 6 and 11 were treated with 6 mg twice daily for approximately six months without improvement. Melatonin was administered for a minimum of three months for each dog, with a maximum of 12 months before discontinuation. Dogs 5 and 6 failed to respond to 0.02 mg/kg p.o. L-thyroxine supplementation (Thyro-Tabs â , Lloyd, Inc.; Shenandoah, IA, USA) administered twice daily for at least six months. In addition, Dog 5 was treated with finasteride (0.35 mg/kg p.o., Teva Pharmaceuticals; North Wales, PA, USA) once daily for 120 days and ciclosporin (5 mg/kg p.o., Atopica â , Novartis Animal Health; Greensboro, NC, USA) once daily for 120 days with no improvement. General physical examination findings provided by primary care veterinarians revealed no significant findings for any dog. Reports provided by owners via a questionnaire submitted to the primary investigator ( 
Clinicopathological results
The CBC, serum chemistry panel and UA results were within normal limits for all dogs. Specifically, the alkaline phosphatase concentration for all dogs was less than 115 U/L (normal range 13-240 U/L) and urine specific gravity was >1.030 except for one affected dog with a result of 1.018. None of the dogs had T 4 or fT 4 ed concentrations below the reference intervals for the laboratory or TSH above the reference interval for the laboratory (Table 1) . Results of the UCCR were considered increased (>13.5) in one of three healthy dogs and three of eight affected dogs (Table 1) . Cortisol and adrenal sex-and steroid-hormone intermediates are shown in Table 2 . Baseline ACTH cortisol concentrations were increased in two unaffected dogs (insufficient serum was available for Dog 2) and three of eight affected dogs; post-ACTH cortisol concentrations were all <15 lg/dL. Baseline androstenedione concentrations were increased for all dogs; two of three healthy and five of eight affected dogs also had increased post-ACTH androstenedione concentrations. Pre-and post-ACTH stimulation estradiol concentrations were increased in all healthy dogs; of the affected dogs, four of eight had increased pre-ACTH stimulation estradiol concentrations and five of eight had increased post-ACTH stimulation estradiol concentrations. Baseline and post-ACTH stimulation progesterone concentrations were increased in one of three healthy dogs and two of eight affected dogs; only post-ACTH stimulation progesterone concentrations were increased in two of eight affected dogs. Baseline 17-hydroxyprogesterone concentrations were increased in one healthy dog (insufficient sample for Dog 2) and two of eight affected dogs; post-ACTH stimulation 17-hydroxyprogesterone concentrations were increased in three of eight affected dogs.
Histopathological results
In biopsies from healthy dogs, hyperkeratosis was absent in two of three dogs and mild in a single dog. Infundibular hyperkeratosis and follicular casts were absent in all dogs. The epidermis was one to two cell layers thick in all dogs and epidermal and or follicular pigment was absent. All dogs had numerous anagen follicles; the majority of hair follicles were haired telogen and all dogs had telogen hairs with trichilemmal keratinization (flame follicles). Dermal inflammation, follicular atrophy, follicular dystrophy, and sebaceous or sweat gland changes were absent in all dogs. Average dermal thickness was 1.45 mm.
In affected schipperkes, all biopsies had mild (six of eight) or moderate (two of eight) epidermal hyperkeratosis, and mild (four of eight) or moderate (four of eight) infundibular hyperkeratosis. Follicular casts were absent in all dogs. The epidermis was one to two cell layers thick in three of eight dogs and up to three layers thick in the remaining five dogs. Epidermal pigmentation was absent in four of eight mild and multifocal in one of eight and moderate to marked and diffuse in three of eight dogs. Prominent melanin clumping limited to few hair bulbs occurred in four of eight dogs, was present in a few hair shafts in three of eight and present in a rare sebaceous or sweat Moderate hyperkeratosis, moderate diffuse epidermal hyperpigmentation and moderate infundibular hyperkeratosis with mild distortion of follicular profiles (follicular dysplasia). Note the presence of multiple haired telogen follicles with prominent trichilemmal keratinization typical of plushcoated breeds (thick arrows) as well as multiple, nonhaired telogen (kenogen) follicles (thin arrows) with excessive trichilemmal keratinization which extends, flame-like, through the outer root sheath, characteristic of flame follicles. Haematoxylin and eosin (H&E). Inset: Kenogen hair follicles, H&E.
gland in one dog each. All but one dog had numerous telogen hair follicles with excessive trichilemmal keratinization (flame follicles). Telogen follicles generally contained a hair although all sections contained at least one nonhaired telogen (kenogen) follicle. In alopecic areas, anagen hair follicles were rare in four of eight dogs, absent in three of eight and abundant in a single dog. Hair follicle atrophy was present in all except one dog and occasional hair follicles were malformed in three of eight dogs. The average dermal thickness was 0.96 mm for affected schipperkes. Sebaceous glands were normal and dermal inflammation, save for scattered perivascular lymphocytes or plasma cells, was absent in all sections (Figure 2 ).
Discussion
This is the first report of a specific syndrome of hair coat colour change and regionally extensive hair loss in the schipperke dog. The distribution of hair loss and pattern of sex and steroid intermediate hormone elevations closely resembles that of the Pomeranian, as described previously. 11 Hyperpigmentation in addition to hair coat loss, although recognized clinically in the Pomeranian, was not a consistent clinical or histological feature in this study. Hair growth and loss in affected schipperkes did not follow a cyclic pattern. Once loss began, it was variably progressive, with time to maximal loss spanning months to years. Two dogs had hair regrowth at the biopsy sites, similar to that described for Alopecia X. 3 Melatonin resulted in partial hair regrowth in only one of four schipperke dogs. A larger treatment group would be needed for direct comparison to Pomeranian dogs. 7 Truncal hair coat lightening and reddish discolouration before loss is not reported in association with the disorder in Pomeranian dogs, even in those with black coat colour. 12 A small case series did mention coat colour darkening in an intact male chow chow and an intact male Pomeranian, described as changing from tan to rust with black streaks. 4 The hair coat colour returned to normal for both dogs with hair regrowth. 4 It is unclear if coat colour changes occur in other breeds diagnosed with Alopecia X as it has not been reported. The schipperke appears to be unique in that hair likely stays in an arrested stage and is eventually worn and bleached, and not as many dogs seem to develop alopecia to the extent the Pomeranian does. Conditions that are commonly known to contribute to development of a reddish hair coat change have been described previously 13 , including poor quality diet, amino acid deficiencies, hypothyroidism, hypercortisolaemia or sex hormone abnormalities. However, in the present study, the coat changes in affected schipperkes developed in dogs that were otherwise healthy and did not have systemic abnormalities. We believe affected schipperkes have an arrest in hair follicle cycling while retaining the damaged hair, resulting in a lighter reddish colour affecting the trunk only; the remainder of the coat is believed to continue cycling normally. Because schipperkes are black in colour, contrast between the truncal reddish colour and the normal dark black hair on the extremities is especially striking. The reddish colour change is a consistent feature because all of the dogs are solid black; thus, the colour slowly changes to a reddish-brown as the more environmentally stable phaeomelanin content becomes visible in noncycling, damaged hair.
14,15 A colour change of some sort may occur in other breeds with Alopecia X yet may not be as obvious because other breeds studied do not typically have such a dark coat colour.
Both hypothyroidism and hypercortisolaemia were excluded as a cause for the alopecia in these schipperke dogs. Thyroid function was considered normal for all dogs and although several dogs had increased baseline cortisol concentrations, cortisol concentrations post-ACTH stimulation were <15 lg/dL for all dogs, which is not supportive of a diagnosis of hypercortisolaemia. Although the low dose dexamethasone suppression test (LDDST) would be considered a more sensitive test for the diagnosis of hypercortisolemia, 16 the lack of clinical signs other than hair coat changes coupled with normal cortisol concentrations post-ACTH stimulation make this diagnosis unlikely. Results of the UCCR from one of the healthy dogs and three of the affected dogs were increased, possibly due to the stress of collection. Although urine collected at home is intended to minimize stress, not all of the dogs were accustomed to leash-walking or having urine collected. The UCCR has been shown to have poor specificity for diagnosing hypercortisolaemia, especially when performed in a stressful environment. 16, 17 Ideally, urine samples for UCCR analysis would have been collected on consecutive days to more accurately characterize a single elevated ratio finding. Unfortunately, this was not part of the study design. Two of the dogs with abnormal UCCR results also had elevated baseline cortisol values, supporting attribution of the abnormal findings to patient stress. However, without LDDST results available for comparison to the increased baseline cortisol concentrations and UCCR results reported, abnormal regulation of cortisol production as previously reported cannot be ruled out. 8 Although the most common abnormality noted in this study was increased baseline and/or post-stimulation androstenedione, results of adrenal steroid and sex hormone testing from all dogs (100%), including the healthy controls, showed increased concentrations of one or more hormones above the reference range at baseline and/or post ACTH-stimulation. These results convincingly exclude the likelihood of adrenal sex hormones as a mechanism for coat changes in this breed. They also are similar to those for other breeds that develop Alopecia X, including the Pomeranian, keeshond, Siberian husky and miniature poodle. 6, 7 Although novel mechanisms for dysregulation of sex hormone metabolism in Pomeranians with Alopecia X have been proposed, they remain unproven. 18 When compared to normal-coated schipperkes, affected animals in this study had changes similar to those described previously in Pomeranians 19 and other plush-coated breeds. 20 Although the majority of noninflammatory alopecic conditions cannot be diagnosed definitely with histopathology alone, 20 there are multiple features previously described and confirmed in the affected schipperkes which support a similarity to Alopecia X. In Alopecia X, the dermis thickness is generally decreased, 19 consistent with the findings in our study where the average dermal thickness in control animals was 1.45 mm compared to 0.96 mm in affected animals. Additionally, dogs with Alopecia X consistently have fewer anagen follicles and significantly more haired telogen follicles, as confirmed in this study. Finally, the presence of abundant flame follicles in all but one dog supports the primary diagnosis of Alopecia X in these animals.
In conclusion, this study describes a noninflammatory alopecia of schipperke dogs with many clinical and histological similarities to Alopecia X. More work is needed to determine the mechanism of the alopecia and the link, if any, to the coat colour changes that are observed.
Resumen
Introducci on -algunos perros de raza Schipperke desarrollan una alopecia bilateral sim etrica precedida por un disminuci on de la capa de pelo no asociada con signos cl ınicos sist emicos. La alopecia se diagnostica presuntamente como alopecia X, pero nunca se ha investigado. Hip otesis/Objetivos -el prop osito de este estudio fue describir las caracter ısticas cl ınicas, las anomal ıas histopatol ogicas y de laboratorio asociadas con la alopecia sim etrica no inflamatoria en pacientes de raza Schipperke. Animales -tres Schipperkes sanos y ocho afectados. M etodos -hemograma completo (CBC), panel de qu ımica del suero, an alisis de orina (UA), relaci on cortisol/creatinina en la orina (UCCR), tiroxina total (T4), tiroxina libre mediante di alisis de equilibrio (fT4ed), hormona estimulante de la tiroides (TSH) y an alisis de cortisol antes y despu es de la estimulaci on con evaluaci on de las hormonas sexuales para todos los perros. Se tomaron muestras de un m ınimo de dos sitios de biopsia de piel para la evaluaci on histopatol ogica. Resultados -el CBC, el panel de qu ımica del suero, UA, T4, fT4ed, TSH y las concentraciones de cortisol post-ACTH fueron normales para todos los perros. Las concentraciones de androstenediona estaban incrementadas en todos los perros; dos de los tres perros sanos y cinco de los ocho afectados tuvieron un aumento de las concentraciones de androstenediona post-ACTH. Las concentraciones de estradiol estaban incrementadas para todos los perros sanos y cuatro de ocho afectados, con las concentraciones de estradiol post ACTH aumentadas para todos los perros sanos y cinco de ocho afectados. Las concentraciones de progesterona estaban aumentadas en dos de tres perros sanos y cuatro de ocho afectados. Las concentraciones de progesterona post-ACTH se incrementaron para uno de tres perros sanos y cuatro de ocho afectados. Para uno de tres perros sanos y dos de ocho afectados, las concentraciones de 17-hidroxiprogesterona estaban aumentadas; las concentraciones de 17-hidroxiprogesterona post-ACTH aumentaron solo en tres de los ocho perros afectados. Los resultados de la histopatolog ıa de los perros afectados fueron consistentes con la interrupci on del ciclo capilar. Conclusiones e importancia cl ınica -este trastorno se parece a la alopecia X cl ınica e histol ogicamente. 
